Trial To Test Use Of TB Vaccine Against Type 1 Diabetes.

Researchers are launching a clinical trial to see if a vaccine approved long ago to prevent tuberculosis may also hold promise as a treatment for type 1 diabetes. The proposed five-year study is designed to investigate whether repeated injections of the tuberculosis vaccine bacille Calmette-Guerin (or BCG vaccine) can quiet the immune system attack that causes type 1 diabetes and improve blood sugar levels in people with long-standing diabetes. "BCG is showing so much promise in worldwide trials [for conditions such as multiple sclerosis]," said study author Dr. Denise Faustman, director of the immunobiology laboratory at Massachusetts General Hospital in Boston. http://consumer.healthday.com/clinical-trials-information-35/clinical-trials-news-136/new-trial-to-test-whether-tb-vaccine-fights-type-1-diabetes-700171.html